Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Denali Therapeutics Inc’s stock clocked out at $26.83, down -4.18% from its previous closing price of $28.00. In other words, the price has decreased by -$4.18 from its previous closing price. On the day, 0.74 million shares were traded. DNLI stock price reached its highest trading level at $27.943 during the session, while it also had its lowest trading level at $26.64.
Ratios:
To gain a deeper understanding of DNLI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.46 and its Current Ratio is at 12.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 13, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $32.Citigroup initiated its Buy rating on December 13, 2023, with a $32 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 30 ’24 when Krognes Steve E. sold 30,000 shares for $29.03 per share. The transaction valued at 870,900 led to the insider holds 29,096 shares of the business.
STEVE KROGNES bought 30,000 shares of DNLI for $882,900 on Sep 30 ’24. On Sep 13 ’24, another insider, SATO VICKI L, who serves as the Director of the company, sold 1,020 shares for $30.00 each. As a result, the insider received 30,600 and left with 115,156 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 4008616704 and an Enterprise Value of 2993831936. For the stock, the TTM Price-to-Sale (P/S) ratio is 3024.40 while its Price-to-Book (P/B) ratio in mrq is 2.77. Its current Enterprise Value per Revenue stands at 2362.93 whereas that against EBITDA is -6.053.
Stock Price History:
Over the past 52 weeks, DNLI has reached a high of $32.13, while it has fallen to a 52-week low of $14.56. The 50-Day Moving Average of the stock is 2.05%, while the 200-Day Moving Average is calculated to be 25.94%.
Shares Statistics:
It appears that DNLI traded 940.43K shares on average per day over the past three months and 675200 shares per day over the past ten days. A total of 138.39M shares are outstanding, with a floating share count of 119.11M. Insiders hold about 16.80% of the company’s shares, while institutions hold 84.20% stake in the company. Shares short for DNLI as of 1727654400 were 7735501 with a Short Ratio of 8.23, compared to 1724976000 on 9014065. Therefore, it implies a Short% of Shares Outstanding of 7735501 and a Short% of Float of 6.329999999999999.
